BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doshi BS, Rana J, Castaman G, Shaheen MA, Kaczmarek R, Butterfield JS, Meeks SL, Leissinger C, Biswas M, Arruda VR. B cell-activating factor modulates the factor VIII immune response in hemophilia A. J Clin Invest 2021;131:142906. [PMID: 33651716 DOI: 10.1172/JCI142906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi Y, Lu A, Wang X, Belhadj Z, Wang J, Zhang Q. A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharm Sin B 2021;11:2396-415. [PMID: 34522592 DOI: 10.1016/j.apsb.2021.05.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang F, Xu Z, He X, Sun Y, Zhao C, Zhang J, Jiang WH. Increased B Cell-Activating Factor Expression Is Associated with Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps. Mediators of Inflammation 2022;2022:1-11. [DOI: 10.1155/2022/7338692] [Reference Citation Analysis]
3 Hodeib H, El Amrousy D, Youssef A, Elaskary E, Fouda MH. BAFF rs9514828 gene polymorphism and the risk of the development of inhibitors in children with severe haemophilia A. Haemophilia 2022. [PMID: 35316553 DOI: 10.1111/hae.14555] [Reference Citation Analysis]